Literature DB >> 17007037

Diagnostic dilemma between intestinal Behçet disease and inflammatory bowel disease with pyoderma gangrenosum.

Cem Evereklioglu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17007037      PMCID: PMC4088185          DOI: 10.3748/wjg.v12.i35.5748

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  40 in total

1.  Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker?

Authors:  Cem Evereklioglu; Yusuf Turkoz; Hamdi Er; H Serhat Inaloz; Emin Ozbek; Mustafa Cekmen
Journal:  J Am Acad Dermatol       Date:  2002-01       Impact factor: 11.527

Review 2.  [Behçet's disease associated with Crohn's disease].

Authors:  H Houman; F Ben Dahmen; I Ben Ghorbel; S Chouaib; M Lamloum; N Kchir; A Ben Ammar; M Miled
Journal:  Ann Med Interne (Paris)       Date:  2001-11

3.  Intestinal involvement in children with Behçet's disease.

Authors:  Federico Marchetti; Chiara Trevisiol; Alessandro Ventura
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

4.  Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease--a multicenter study. The Behcet's Disease Research Committee of Japan.

Authors: 
Journal:  J Rheumatol       Date:  1989-04       Impact factor: 4.666

Review 5.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

6.  Cyclosporine in Behçet's disease resistant to conventional therapy.

Authors:  L E Caspers-Velu; G Decaux; J Libert
Journal:  Ann Ophthalmol       Date:  1989-03

7.  Increased plasma adrenomedullin levels in patients with Behçet's disease.

Authors:  C Evereklioglu; M Yurekli; H Er; E Ozbek; E Hazneci; M Cekmen; H S Inaloz
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

8.  Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity.

Authors:  C Evereklioglu; H S Inalöz; N Kirtak; S Doganay; M Bülbül; E Ozerol; H Er; E Ozbek
Journal:  Br J Dermatol       Date:  2002-08       Impact factor: 9.302

9.  Urinary adrenomedullin levels are increased and correlated with plasma concentrations in patients with Behçet's syndrome.

Authors:  Cem Evereklioglu; Emin Ozbek; Hamdi Er; Mustafa Cekmen; Muhittin Yürekli
Journal:  Int J Urol       Date:  2002-06       Impact factor: 3.369

10.  Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.

Authors:  Cem Evereklioglu; Hamdi Er; Yusuf Türköz; Mustafa Cekmen
Journal:  Mediators Inflamm       Date:  2002-04       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.